Doug Sborov, MD, MS

• Multiple Myeloma

Dr. Douglas Sborov is an Associate Professor in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine. He was born and raised in Minnesota, completed his undergraduate education with a Bachelor of Science at the University of Wisconsin-Madison, later completed medical school through American University of the Caribbean, and spent 3 years in Salt Lake City for his internal medicine residency. After almost 5 years in Columbus, OH, completing hematology, oncology, and bone marrow transplantation fellowships, he joined the Division of Hematology to continue his career as a clinical trialist focused on the treatment of patients with hematologic malignancies. Dr. Sborov is the Director of the Multiple Myeloma Program and Division of Hematology Biorepository, member of the Huntsman Cancer Institute Experimental Therapeutics Program, Physician Leader of the Multiple Myeloma/Bone Marrow Transplant arm of the HCI Clinical Trials Office (CTO), active member of the HCI Protocol Review and Monitoring Committee, and he was recently elected as a Huntsman Translational Scholar. Dr. Sborov’s primary research concentration is the development of novel therapeutics for patients with multiple myeloma. His work has been published in various high impact medical journals including Clinical Cancer Research, Oncotarget, Blood, and the British Journal of Haematology. Along with his work developing novel anticancer agents and regimens, Dr. Sborov is working closely with the entire multiple myeloma team to further develop a state-of-the-art clinical trial and research program that offers patients the opportunity to take part in advancing cutting edge, high quality, next generation treatment options.